HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ki Sung Ryu Selected Research

anti-Mullerian hormone receptor

6/2012Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.
10/2011Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells.
6/2009The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ki Sung Ryu Research Topics

Disease

5Neoplasms (Cancer)
06/2012 - 03/2002
4Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2012 - 11/2002
4Ovarian Neoplasms (Ovarian Cancer)
05/2009 - 03/2002
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2011 - 06/2009
2Ovarian Epithelial Carcinoma
01/2011 - 02/2010
2Aneuploidy (Aneuploid)
06/2003 - 06/2002
2Carcinogenesis
11/2002 - 03/2002
1Carcinoma (Carcinomatosis)
06/2012
1Anemia
01/2011
1Pathologic Complete Response
01/2011
1Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor)
06/2009
1Disease Progression
07/2007
1Breast Neoplasms (Breast Cancer)
06/2002
1Neoplasm Metastasis (Metastasis)
03/2002
1Adenocarcinoma
03/2002
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
03/2002

Drug/Important Bio-Agent (IBA)

3anti-Mullerian hormone receptorIBA
06/2012 - 06/2009
3Biological ProductsIBA
06/2012 - 05/2009
3Messenger RNA (mRNA)IBA
06/2012 - 11/2002
3DNA (Deoxyribonucleic Acid)IBA
05/2009 - 06/2002
2Proteins (Proteins, Gene)FDA Link
06/2012 - 06/2009
2Paclitaxel (Taxol)FDA LinkGeneric
02/2010 - 07/2007
2Keratins (Keratin)IBA
06/2003 - 06/2002
2AntigensIBA
06/2002 - 03/2002
1FITC-annexin A5IBA
06/2012
1ThiazolesIBA
06/2012
1taxaneIBA
01/2011
1PlatinumIBA
01/2011
1Immunologic Factors (Immunomodulators)IBA
06/2009
1Hormones (Hormone)IBA
06/2009
1Carboplatin (JM8)FDA LinkGeneric
07/2007
1Cyclin-Dependent Kinase Inhibitor p16IBA
06/2003
1WD repeat containing planar cell polarity effectorIBA
11/2002
1Complementary DNA (cDNA)IBA
11/2002
1PhycoerythrinIBA
06/2002
1Propidium (Propidium Iodide)IBA
06/2002
1isothiocyanic acidIBA
06/2002
1Fluorescein-5-isothiocyanate (FITC)IBA
06/2002
1Fluorescein (Funduscein)FDA LinkGeneric
06/2002
1paraform (paraformaldehyde)IBA
06/2002
1Methanol (Carbinol)IBA
06/2002
1Histocompatibility Antigens Class IIIBA
03/2002
1Monoclonal AntibodiesIBA
03/2002
1A-factor (Streptomyces)IBA
03/2002
1HLA-B Antigens (HLA-B)IBA
03/2002

Therapy/Procedure

4Therapeutics
10/2011 - 07/2007
3Hyperthermic Intraperitoneal Chemotherapy
02/2010 - 08/2004
1Drug Therapy (Chemotherapy)
01/2011